Portage, IN, United States of America

Christopher James Santee

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Christopher James Santee

Introduction

Christopher James Santee is an accomplished inventor based in Portage, IN (US). He has made significant contributions to the field of pharmaceutical innovations, particularly in the development of oral film compositions. With a total of 3 patents to his name, Santee's work focuses on enhancing drug delivery systems.

Latest Patents

One of Santee's latest patents involves oral film compositions and dosage forms that have precise active dissolution profiles. This innovation presents an oral film in an individual unit dose designed for the delivery of one or more active ingredients. The film is characterized by a precisely calculated and controlled active dissolution profile. A variety of active ingredients can be utilized, including clobazam, diazepam, and riluzole. Additionally, the patent outlines methods for treating various diseases and conditions, such as epilepsy and seizures, through the administration of the disclosed oral film.

Career Highlights

Santee is currently associated with Aquestive Therapeutics, Inc., where he continues to develop innovative solutions in drug delivery. His work has been instrumental in advancing the field of pharmaceuticals, particularly in creating more effective treatment options for patients.

Collaborations

Some of Santee's notable coworkers include Alexander Mark Schobel and Stephen Paul Wargacki. Their collaborative efforts contribute to the innovative environment at Aquestive Therapeutics, Inc.

Conclusion

Christopher James Santee's contributions to the field of pharmaceutical innovations are noteworthy. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients with various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…